KPRX Kiora Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 7, 2026
$2.56
· of 52w range
· above low
· to high
$1.7752w low
$2.9552w high
Market Cap (MRQ)
$11M
P/E
-1.0
EPS
$-2.64
Revenue
$0
your badges
52W Range
$2–$3
Analyst Rating
BUY
Price Target
$12
P/E
-1.0
ROE
-56.6%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
KPRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.56
Market Cap (MRQ)
$11M
P/E
-1.0
EPS
$-2.64
Revenue
$0
ROE
-56.6%
52W Range
$2–$3
KPRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 11, 2024 | 1-for-9 | Reverse |
| Sept. 27, 2022 | 1-for-40 | Reverse |
| Aug. 30, 2019 | 1-for-15 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02016-12-31 → 2025-12-31
EPS$-2.642020-12-31 → 2025-12-31
Free Cash Flow$-10M2017-12-31 → 2025-12-31
Net margin·2016-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | KPRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.05Y avg ≈-1.7 | ≈-1.7 | · | · | |
| P/B (MRQ) | 0.75Y avg ≈96.8 | ≈96.8 | 2.1 | Undervalued | |
| Price / FCF (TTM) | -1.35Y avg ≈-161.5 | ≈-161.5 | · | · | |
| Price / Cash Flow (TTM) | -1.35Y avg ≈-130.7 | ≈-130.7 | · | · | |
| Price / Tangible Book (MRQ) | 0.85Y avg ≈472.7 | ≈472.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | KPRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -35.7%5Y avg ≈-49.3% | ≈-49.3% | -44.9% | Top tier | |
| ROE | -56.6%5Y avg ≈-84.4% | ≈-84.4% | -57.2% | In line | |
| ROIC | -71.2%5Y avg ≈-94.2% | ≈-94.2% | 348.2% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | KPRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 9.05Y avg ≈4.4 | ≈4.4 | 3.1 | Strong liquidity | |
| Quick Ratio (MRQ) | 7.65Y avg ≈3.6 | ≈3.6 | 3.0 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | KPRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.2 | ≈0.2 | 0.1 | Weak | |
| Receivables Turnover | 0.0 | · | 4.5 | Weak | |
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-2.0%
Next Report
Nov 05, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $-0.34 | $-0.63 | 46.2% |
| March 31, 2026 | May 7, 2026 | $-0.58 | $-0.72 | 19.9% |
| Dec. 31, 2025 | $-1.59 | $-0.68 | -132.7% | |
| Sept. 30, 2025 | $0.01 | $-0.75 | 101.3% | |
| June 30, 2025 | $-0.54 | $-0.62 | 12.5% | |
| March 31, 2025 | $-0.52 | $-0.68 | 23.9% | |
| Dec. 31, 2024 | $-1.04 | $-0.56 | -85.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $16M | $0 | · | $0 | $12.1K | $3M | $2M | $407.5K | $669.3K | $0 | |
| R&D Expense | $11M | $8M | $4M | $3M | $5M | $4M | $5M | $8M | $10M | $8M | $3M | |
| SG&A Expense | $6M | $6M | $5M | $8M | $5M | $5M | $4M | $4M | $5M | $6M | $4M | |
| Operating Expenses | $13M | $12M | $13M | $12M | $14M | $7M | $10M | $12M | $15M | $14M | $7M | |
| Operating Income | $-13M | $5M | $-13M | $-12M | $-14M | $-7M | · | $-11M | · | · | · | |
| Interest Expense | · | · | $11.1K | $8.6K | $6.9K | $4.2K | $325 | $1.0K | $1.2K | $275 | $2M | |
| Interest Income | $894.0K | $1M | $174.0K | $56.9K | $1.1K | $23.3K | $108.1K | $120.4K | $564 | $3.7K | $947 | |
| Other Non-op | $-160.3K | $26.1K | $28.8K | $-14.5K | $272.5K | $19.2K | $107.7K | $119.3K | $-651 | $3.4K | $10 | |
| Pretax Income | $-12M | $6M | $-12M | $-14M | $-14M | $-7M | $-7M | $-11M | $-15M | $-13M | $-8M | |
| Income Tax | $-1M | $2M | $90.3K | $-113.0K | $-192.6K | $12.1K | $95.4K | $86.0K | $-1M | $0 | · | |
| Net Income | $-11M | $4M | $-13M | $-14M | $-14M | $-7M | $-7M | $-11M | $-13M | $-13M | $-8M | |
| EPS (Basic) | $-2.60 | $0.93 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · | |
| EPS (Diluted) | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · | |
| Shares (Basic) | 4,166,692 | 3,872,644 | 538,007 | 732,303 | 241,099 | 4,591,491 | · | · | · | · | · | |
| Shares (Diluted) | 4,103,873 | 4,125,075 | 538,007 | 732,303 | 241,099 | 4,591,491 | · | · | · | · | · | |
| EBITDA | $-13M | $5M | $-13M | $-12M | $-14M | $33.4K | $51.7K | $-11M | $19.3K | $5.2K | $1.3K |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $2M | $6M | $8M | $1M | $4M | $8M | $8M | $4M | $8M | |
| Short-term Investments | $8M | $23M | $0 | · | · | · | · | · | · | · | · | |
| Receivables | $2M | $601.2K | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $233.4K | $343.1K | $606.5K | $449.6K | $458.8K | $455.8K | $629.6K | $465.0K | $122.4K | |
| Current Assets | $22M | $30M | $5M | $8M | $9M | $2M | $4M | $8M | $8M | $4M | $9M | |
| PP&E (Net) | $91.7K | $5.2K | $8.1K | $55.2K | $74.0K | $30.6K | $16.8K | $43.5K | $55.8K | $38.0K | $0 | |
| PP&E (Gross) | $117.6K | $6.3K | $14.4K | $172.5K | $187.1K | $123.5K | $99.6K | $99.6K | $79.6K | $42.6K | $268.1K | |
| Accum. Depreciation | $25.9K | $1.0K | $6.3K | $117.3K | $113.1K | $93.0K | $82.7K | $56.1K | $23.8K | $4.5K | $268.1K | |
| Goodwill | · | · | · | $0 | $0 | $4M | $2M | $2M | $2M | · | · | |
| Intangibles | $2M | $7M | $9M | $11M | $11M | $10M | $4M | $4M | $4M | · | · | |
| Other Non-current Assets | $59.7K | $24.9K | $40.8K | $33.0K | $43.0K | $57.1K | $69.4K | $31.7K | $307.1K | $55.3K | $38.6K | |
| Total Assets | $24M | $36M | $14M | $19M | $20M | $15M | $10M | $14M | $14M | $10M | $10M | |
| Accounts Payable | $1M | $415.6K | $206.3K | $1M | $160.6K | $434.8K | $210.3K | $63.7K | $706.1K | $1M | $417.7K | |
| Accrued Liabilities | $2M | $5M | $1M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | $212.3K | · | · | · | · | · | |
| Current Liabilities | $4M | $6M | $2M | $3M | $2M | $2M | $1M | $4M | $15M | $7M | $3M | |
| Capital Leases | $203.8K | $33.8K | $59.8K | $0 | $90.6K | $35.6K | $0 | $0 | $4.9K | $16.1K | $0 | |
| Deferred Tax | $102.2K | $490.7K | $779.4K | $689.1K | $802.1K | $728.9K | $365.4K | $270.0K | $183.9K | $2M | $0 | |
| Total Liabilities | $8M | $11M | $8M | $7M | $6M | $6M | $3M | $5M | $16M | $10M | $3M | |
| Total Debt | · | · | · | · | · | $278.2K | · | · | · | · | · | |
| Common Stock | $275.3K | $267.7K | $77.1K | $18.0K | $3.2K | $55.6K | $40.8K | $30.4K | $172.6K | $101.3K | $76.6K | |
| Paid-in Capital | $170M | $169M | $153M | $146M | $136M | $117M | $107M | $102M | $90M | $78M | $71M | |
| Retained Earnings | $-154M | $-143M | $-147M | $-134M | $-121M | $-107M | $-100M | $-93M | $-92M | $-79M | $-65M | |
| AOCI | $-246.1K | $-282.2K | $-182.8K | $-182.7K | $-86.4K | $-802 | $139.5K | $134.3K | $127.5K | $120.2K | $114.8K | |
| Stockholders' Equity | $16M | $26M | $6M | $11M | $15M | $10M | $7M | $9M | $-2M | $-329.4K | $6M | |
| Liabilities + Equity | $24M | $36M | $14M | $19M | $20M | $15M | $10M | $14M | $14M | $10M | $10M | |
| Shares Outstanding | 3,761,739 | 3,000,788 | 856,182 | 1,796,472 | 316,599 | 5,556,394 | 4,077,755 | 3,038,592 | 17,257,255 | 10,130,883 | 7,657,287 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24.8K | $19.2K | $51.8K | $41.6K | $45.3K | $33.4K | $51.7K | $38.5K | $19.3K | $5.2K | $1.3K | |
| Stock-based Comp | $900.2K | $656.6K | $754.9K | $462.4K | $842.5K | $723.9K | $852.2K | $875.3K | $870.3K | $511.0K | $1M | |
| Deferred Tax | · | · | $90.3K | $-113.0K | $-192.6K | $-12.1K | $-95.4K | $-86.0K | $1M | $0 | · | |
| Amort. of Intangibles | $0 | $15.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $6.2K | $0 | · | · | |
| Other Non-cash | $-51.1K | $4M | $2M | $3M | $2M | $29.6K | $-2M | $-860.8K | $7M | $4M | $3M | |
| Operating Cash Flow | $-10M | $9M | $-10M | $-10M | $-11M | $-7M | $-8M | $-11M | $-6M | $-8M | $-4M | |
| CapEx | $110.8K | $6.3K | $0 | $0 | $63.9K | $20.1K | $0 | $20.0K | $37.0K | $0 | · | |
| Investing Cash Flow | $14M | $-23M | $0 | $6.4K | $-157.0K | $-244.4K | $0 | $-270.0K | $-37.0K | $174.7K | · | |
| Debt Issued | · | · | · | · | $0 | $278.2K | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $0 | $278.2K | · | · | · | · | · | |
| Stock Issued | · | · | · | $5M | $18M | $5M | $2M | $10M | $11M | $4M | $14M | |
| Net Stock Activity | · | · | · | $5M | $19M | $5M | $2M | $10M | $12M | $4M | · | |
| Financing Cash Flow | $265.7K | $15M | $6M | $9M | $18M | $5M | $4M | $11M | $11M | $3M | · | |
| Net Change in Cash | $5M | $1M | $-4M | $-2M | $7M | $-3M | $-4M | $198.2K | $4M | $-5M | $8M | |
| Taxes Paid | $2M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-10M | $9M | · | $-10M | $-11M | $-7M | · | $-11M | $-7M | · | · | |
| Levered FCF | · | · | · | $-10M | $-11M | $-7M | · | $-11M | $-7M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 28.1% | · | · | · | · | · | -656.2% | · | · | · | |
| Net Margin | · | 22.4% | · | · | · | -67102.9% | -264.2% | -654.2% | -3243.5% | -1993.8% | · | |
| Pretax Margin | · | 35.3% | · | · | · | -67002.9% | -260.7% | -649.0% | -3572.8% | -1993.8% | · | |
| EBITDA Margin | · | 28.3% | · | · | · | 277.0% | 1.9% | -653.9% | 4.7% | 0.77% | · | |
| ROA | -35.7% | 14.3% | -77.3% | -70.0% | -77.7% | -64.0% | -58.2% | -75.6% | -110.0% | -138.7% | -153.7% | |
| ROE | -56.6% | 12.9% | -176.1% | -123.9% | -78.5% | -124.9% | -119.9% | -107.9% | 1171.6% | -463.5% | 41.2% | |
| ROIC | -71.2% | 11.1% | -207.5% | -107.0% | -96.3% | · | · | -122.3% | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 4.9 | 2.9 | 2.3 | 5.6 | 1.0 | 3.1 | 2.2 | 0.6 | 0.6 | 2.8 | |
| Quick Ratio | 5.1 | 4.6 | 1.5 | 1.8 | 4.9 | 0.7 | 2.7 | 2.1 | 0.5 | 0.5 | 2.5 | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -1130.7 | -1431.5 | -2077.9 | · | · | -10427.6 | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.6 | · | · | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | 0.1 | · | |
| Receivables Turnover | 0.0 | 53.3 | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.29 | $8.58 | $0.79 | $6.35 | $1.15 | $1.26 | $1.62 | $0.20 | $-0.11 | $-0.03 | $0.79 | |
| Revenue / Share | $0.00 | $3.88 | · | · | $0.00 | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.43 | $2.07 | $-1.97 | $-14.24 | $-1.11 | · | · | · | · | · | · | |
| Cash / Share | $2.31 | $1.26 | $0.32 | $3.32 | $0.62 | $0.21 | $0.93 | $0.18 | $0.45 | $0.36 | $1.10 | |
| EPS (TTM) | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $16M | $0 | $0 | $0 | $12.1K | $3M | $2M | $407.5K | $669.3K | $0 | |
| Net Income TTM | $-11M | $4M | $-13M | $-14M | $-14M | $-7M | $-7M | $-11M | $-13M | $-13M | $-8M | |
| Market Cap | $7M | $10M | $36M | $55M | $6.88B | $9.86B | $14.71B | $109.97B | $99.71B | $89.17B | $113.30B | |
| Enterprise Value | · | · | · | · | · | $9.86B | · | · | · | · | · | |
| P/E | -0.7 | 3.8 | -0.2 | -1.7 | -9.5 | -1191.1 | · | · | · | · | · | |
| P/S | · | 0.6 | · | · | · | 817770.0 | 5476.3 | 66544.7 | 244682.2 | 133239.9 | · | |
| P/B | 0.5 | 0.4 | 5.9 | 4.9 | 472.2 | 1408.9 | 2221.1 | 12305.6 | -51747.0 | -270693.2 | 18613.7 | |
| P / Tangible Book | 0.5 | 0.5 | · | 83.5 | 1806.4 | · | · | · | · | · | · | |
| P / Cash Flow | -0.7 | 1.2 | -3.8 | -5.3 | -644.9 | -1347.7 | -1804.0 | -10140.3 | -15415.0 | -10599.1 | -25407.7 | |
| P / FCF | -0.7 | 1.2 | · | -5.3 | -641.0 | -1344.0 | · | -10121.6 | -15327.3 | · | · | |
| EV / EBITDA | · | · | · | · | · | 295235.8 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -1343.9 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | 817694.7 | · | · | · | · | · | |
| Earnings Yield | -134.0% | 26.4% | -516.2% | -60.1% | -10.5% | -0.08% | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $20.0K | $16M | $0 | $0 | $0 | $0 | · | · | |
| R&D Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $438.3K | $841.6K | $1M | |
| SG&A Expense | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $880.5K | $1M | $1M | $1M | $3M | $2M | |
| Operating Expenses | $2M | $3M | $7M | $794.4K | $2M | $2M | $3M | $4M | $3M | $3M | $2M | $6M | $3M | $2M | $3M | $4M | |
| Operating Income | $-2M | $-3M | $-7M | $-794.4K | $-2M | $-2M | $-3M | $-4M | $-3M | $13M | $-2M | $-6M | $-3M | $-2M | $-3M | $-4M | |
| Interest Income | · | · | · | · | $225.2K | $277.3K | · | · | $342.1K | $223.2K | · | · | · | · | · | · | |
| Other Non-op | $-11.5K | $-47.1K | $-26.8K | $-23.7K | $-93.6K | $-16.3K | $96.8K | $-59.9K | $-18.9K | $8.1K | $-65.7K | $105.7K | $-25.9K | $14.7K | $-15.4K | $937 | |
| Pretax Income | $-2M | $-2M | $-7M | $-616.3K | $-2M | $-2M | $-2M | $-3M | $-2M | $13M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $-650.0K | $-643.1K | $-112.1K | $123.0K | $2M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-7M | $26.8K | $-2M | $-2M | $-4M | $-3M | $-2M | $13M | $-2M | $-6M | $-3M | $-2M | $-2M | $-5M | |
| EPS (Basic) | $-0.34 | $-0.58 | $-1.55 | $0.01 | $-0.54 | $-0.52 | $-2.40 | $-0.81 | $-0.53 | $4.67 | $-8.80 | $-7.30 | $-7.15 | $-1.00 | $-1.07 | $-6.03 | |
| EPS (Diluted) | $-0.34 | $-0.58 | $-1.59 | $0.01 | $-0.54 | $-0.52 | $-1.25 | $-0.81 | $-0.53 | $3.46 | $-8.80 | $-7.30 | $-7.15 | $-1.00 | $-1.07 | $-6.03 | |
| Shares (Basic) | 6,177,679 | 4,174,802 | · | 4,289,853 | 3,989,042 | 4,217,007 | · | 4,214,950 | 4,170,627 | 2,881,796 | · | 789,656 | 365,530 | 1,863,466 | · | 848,534 | |
| Shares (Diluted) | 6,177,679 | 4,174,802 | · | 4,361,740 | 3,989,042 | 4,217,007 | · | 4,214,950 | 4,170,627 | 3,891,722 | · | 789,656 | 365,530 | 1,863,466 | · | 848,534 | |
| EBITDA | $-2M | $-2M | · | $-794.4K | $-2M | $-2M | · | $-4M | $-3M | $13M | · | $-6M | $-3M | $-2M | · | $-4M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $11M | $9M | $6M | $1M | $4M | $4M | $6M | $7M | $31M | $2M | $5M | $8M | $3M | $6M | $5M | |
| Short-term Investments | $10M | $3M | $8M | $14M | $20M | $20M | $23M | $23M | $21M | · | $0 | · | · | · | · | · | |
| Receivables | $1M | $2M | $2M | $1M | $2M | $1M | $601.2K | $2M | $1M | $189.9K | $0 | · | · | · | · | · | |
| Prepaid Expense | $1M | $1M | $1M | $650.4K | $957.1K | $941.5K | $2M | $470.4K | $339.6K | $206.7K | $233.4K | $239.4K | $266.5K | $488.9K | $343.1K | $260.0K | |
| Current Assets | $21M | $19M | $22M | $23M | $25M | $27M | $30M | $32M | $32M | $33M | $5M | $7M | $9M | $6M | $8M | $7M | |
| PP&E (Net) | $99.6K | $86.8K | $91.7K | $101.8K | $106.8K | $5.0K | $5.2K | $62.6K | $63.5K | $12.9K | $8.1K | $38.6K | $44.9K | $51.3K | $55.2K | $59.2K | |
| PP&E (Gross) | · | · | $117.6K | · | · | · | $6.3K | · | · | · | $14.4K | · | · | · | $172.5K | · | |
| Accum. Depreciation | · | · | $25.9K | · | · | · | $1.0K | · | · | · | $6.3K | · | · | · | $117.3K | · | |
| Intangibles | $2M | $2M | $2M | $7M | $7M | $7M | $7M | $7M | $9M | $9M | $9M | $9M | $11M | $11M | $11M | $11M | |
| Other Non-current Assets | $85.4K | $88.2K | $59.7K | $58.1K | $61.0K | $64.3K | $24.9K | $29.9K | $32.1K | $39.4K | $40.8K | $32.0K | $32.4K | $32.7K | $33.0K | $33.0K | |
| Total Assets | $24M | $21M | $24M | $30M | $32M | $34M | $36M | $39M | $41M | $42M | $14M | $16M | $20M | $17M | $19M | $18M | |
| Accounts Payable | $216.5K | $594.9K | $1M | $241.5K | $282.5K | $942.5K | $415.6K | $660.4K | $268.6K | $323.1K | $206.3K | $125.4K | $131.3K | $587.5K | $1M | $749.2K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Current Liabilities | $2M | $3M | $4M | $3M | $3M | $5M | $6M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Capital Leases | $160.6K | $195.4K | $203.8K | $248.2K | $287.1K | $87.5K | $33.8K | $39.2K | $40.2K | $46.4K | $59.8K | $0 | $0 | $0 | $0 | $4.8K | |
| Deferred Tax | $102.2K | $102.2K | $102.2K | $490.7K | $490.7K | $490.7K | $490.7K | $779.4K | $779.4K | $779.4K | $779.4K | $689.1K | $689.1K | $689.1K | $689.1K | $802.1K | |
| Total Liabilities | $7M | $7M | $8M | $7M | $10M | $10M | $11M | $8M | $8M | $8M | $8M | $8M | $6M | $6M | $7M | $7M | |
| Common Stock | $281.9K | $277.6K | $275.3K | $272.0K | $272.0K | $267.7K | $267.7K | $267.7K | $267.4K | $262.6K | $77.1K | $76.9K | $69.1K | $19.2K | $18.0K | $10.8K | |
| Paid-in Capital | $176M | $171M | $170M | $170M | $170M | $169M | $169M | $169M | $169M | $168M | $153M | $153M | $153M | $147M | $146M | $143M | |
| Retained Earnings | $-159M | $-157M | $-154M | $-148M | $-148M | $-146M | $-143M | $-139M | $-136M | $-134M | $-147M | $-145M | $-139M | $-136M | $-134M | $-132M | |
| AOCI | $-255.8K | $-228.8K | $-246.1K | $-243.7K | $-245.8K | $-297.2K | $-282.2K | $-75.2K | $-245.7K | $-264.4K | $-182.8K | $-266.2K | $-225.9K | $-215.4K | $-182.7K | $-263.4K | |
| Stockholders' Equity | $17M | $14M | $16M | $22M | $22M | $24M | $26M | $30M | $33M | $35M | $6M | $8M | $14M | $10M | $11M | $11M | |
| Liabilities + Equity | $24M | $21M | $24M | $30M | $32M | $34M | $36M | $39M | $41M | $42M | $14M | $16M | $20M | $17M | $19M | $18M | |
| Shares Outstanding | 4,427,167 | 3,993,469 | 3,761,739 | 3,433,491 | 3,433,491 | 3,000,788 | 3,000,788 | 3,000,788 | 2,970,545 | 26,256,197 | 856,182 | 7,689,240 | 6,910,720 | 1,919,270 | 1,796,472 | 1,079,045 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10.7K | $10.6K | $10.5K | $10.6K | $3.4K | $318 | $5.9K | $2.1K | $6.3K | $4.9K | $7.9K | $11.3K | $22.5K | $10.1K | $10.3K | $10.3K | |
| Stock-based Comp | $109.3K | $209.5K | $234.4K | $254.4K | $262.8K | $148.6K | $160.2K | $171.2K | $149.8K | $175.4K | $182.3K | $264.9K | $171.8K | $135.9K | $45.1K | $130.2K | |
| Other Non-cash | · | $-963.4K | · | · | · | $-660.2K | · | · | · | $-8.7K | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-2M | $-3M | $-2M | $-1M | $-4M | $-3M | $-2M | $920.1K | $-4M | $14M | $-3M | $-3M | $-1M | $-3M | $-2M | $-3M | |
| CapEx | $23.5K | $5.0K | $78.2K | $431 | $32.2K | $0 | $-45.0K | $0 | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $-7M | $5M | $5M | $6M | $664.2K | $3M | $482.7K | $-2M | $-21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $343.4K | $99.0K | · | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $99.0K | · | · | |
| Financing Cash Flow | $5M | $-842 | $296 | $0 | $265.4K | $0 | $0 | $0 | $250.5K | $15M | $-486.4K | $0 | $6M | $513.2K | $3M | $5M | |
| Net Change in Cash | $-4M | $2M | $3M | $4M | $-3M | $-21.3K | $-2M | $-938.0K | $-25M | $29M | $-3M | $-3M | $5M | $-3M | $1M | $2M | |
| Free Cash Flow | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -12724.4% | 82.6% | · | -11858.0% | -5839.8% | -5727.4% | · | -47106.4% | |
| Net Margin | · | · | · | · | · | · | · | · | -11108.2% | 84.1% | · | -11546.2% | -5797.3% | -5583.6% | · | -65123.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -12724.4% | 82.7% | · | -11858.0% | -5839.8% | -5697.3% | · | -47106.4% | |
| ROA | -7.5% | -8.8% | · | 0.08% | -5.9% | -5.7% | · | -12.6% | -7.3% | 45.6% | · | -34.4% | -14.8% | -10.9% | · | -23.7% | |
| ROE | -10.7% | -12.8% | · | 0.10% | -7.8% | -7.5% | · | -17.9% | -9.5% | 59.7% | · | -61.9% | -23.3% | -17.4% | · | -36.7% | |
| ROIC | -13.1% | -18.0% | · | 0.15% | -10.3% | -10.4% | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 6.7 | · | 8.8 | 7.8 | 5.1 | · | 9.0 | 19.2 | 21.0 | · | 3.3 | 4.8 | 2.6 | · | 2.2 | |
| Quick Ratio | 7.6 | 5.5 | · | 8.0 | 7.2 | 4.8 | · | 8.7 | 17.6 | 19.8 | · | 2.6 | 4.2 | 1.6 | · | 1.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.5 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 168.5 | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.81 | $3.49 | · | $6.53 | $6.44 | $7.90 | · | $10.01 | $11.14 | $1.33 | · | $1.05 | $1.97 | $5.29 | · | $9.75 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.46 | · | $0.01 | $0.01 | $0.02 | · | $0.01 | |
| Cash Flow / Share | · | $-0.76 | · | · | · | $-0.64 | · | · | · | $0.39 | · | · | · | $-1.65 | · | · | |
| Cash / Share | $1.60 | $2.74 | · | $1.60 | $0.30 | $1.26 | · | $1.88 | $2.21 | $1.19 | · | $0.70 | $1.15 | $1.79 | · | $4.45 | |
| EPS (TTM) | $-2.50 | $-2.70 | · | $-2.30 | $-3.12 | $-3.11 | · | $-6.68 | $-13.17 | $-19.79 | · | $-16.52 | $-15.25 | $-8.28 | · | $-62.65 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $20.0K | · | $16M | $16M | $16M | · | · | · | · | · | $12.1K | |
| Net Income TTM | $-11M | $-11M | · | $-9M | $-12M | $-12M | · | $6M | $3M | $3M | · | $-13M | $-12M | $-12M | · | $-17M | |
| Market Cap | $12M | $8M | · | $10M | $10M | $9M | · | $11M | $12M | $167M | · | $39M | $40M | $58M | · | $60M | |
| P/E | -1.1 | -0.7 | · | -1.2 | -0.9 | -1.0 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -3.6 | · | -0.9 | |
| P/S | · | · | · | · | · | 451.6 | · | 0.7 | 0.8 | 10.4 | · | · | · | · | · | 4952.7 | |
| P/B | 0.7 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 4.8 | · | 4.9 | 2.9 | 5.7 | · | 5.7 | |
| P / Tangible Book | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 6.4 | · | · | 13.7 | · | · | · | |
| P / Cash Flow | · | -2.4 | · | · | · | -3.3 | · | · | · | 12.2 | · | · | · | -18.8 | · | · | |
| Earnings Yield | -95.1% | -139.9% | · | -82.7% | -108.3% | -103.3% | · | -182.5% | -313.6% | -311.5% | · | -323.2% | -263.5% | -27.5% | · | -113.2% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $0 | $16M | $0 | · | $0 |
| Operating Margin % | · | 28.1% | · | · | · |
| Net Income | $-11M | $4M | $-13M | $-14M | $-14M |
| Diluted EPS | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 6.0 | 4.9 | 2.9 | 2.3 | 5.6 |
| Quick Ratio | 5.1 | 4.6 | 1.5 | 1.8 | 4.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-10M | $9M | · | $-10M | $-11M |
Institutional owners (13F) 23 filers · $2.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
23
Value held
$2.8M
New positions
10
Exited positions
6
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 10 (+3 vs prior Q) | 6 (0 vs prior Q) | 3 (-1 vs prior Q) | 2 (+1 vs prior Q) | +766K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $1,153,179 | 438,471 | 40.91% | Shares |
| ADAR1 Capital Management, LLC | $441,685 | 167,941 | 15.67% | Shares |
| CITADEL ADVISORS LLC | $305,109 | 116,011 | 10.82% | Shares |
| TWO SIGMA INVESTMENTS, LP | $233,523 | 88,792 | 8.28% | Shares |
| MILLENNIUM MANAGEMENT LLC | $195,151 | 74,202 | 6.92% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $78,437 | 29,824 | 2.78% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $70,264 | 26,717 | 2.49% | Shares |
| VANGUARD GROUP INC | $65,189 | 33,091 | 2.31% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $52,234 | 19,861 | 1.85% | Shares |
| Scientech Research LLC | $49,302 | 18,746 | 1.75% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $34,269 | 13,030 | 1.22% | Shares |
| LPL Financial LLC | $32,875 | 12,500 | 1.17% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $31,923 | 12,138 | 1.13% | Shares |
| NORTHERN TRUST CORP | $30,947 | 11,767 | 1.10% | Shares |
| JANE STREET GROUP, LLC | $27,918 | 10,615 | 0.99% | Shares |
| UBS Group AG | $5,157 | 1,961 | 0.18% | Shares |
| Caitong International Asset Management Co., Ltd | $4,768 | 1,813 | 0.17% | Shares |
| MORGAN STANLEY | $3,703 | 1,408 | 0.13% | Shares |
| Tower Research Capital LLC (TRC) | $2,201 | 837 | 0.08% | Shares |
| SBI Securities Co., Ltd. | $673 | 256 | 0.02% | Shares |
| HRT FINANCIAL LP | $154 | 58,612 | 0.01% | Shares |
| BlackRock, Inc. | $153 | 58 | 0.01% | Shares |
| Activest Wealth Management | $5 | 2 | 0.00% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Armistice Capital, LLC, Steven Boyd ×10 filings | Aug. 3, 2021 | · | Initial filing | Board campaign | SEC |
| IPSA (formerly Innoven Partenaires S.A.), FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Capital 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI La Banque Postale Innovation 1, Jean-Michel Paulhac ×3 filings | Jan. 17, 2018 | · | Initial filing | Passive investment | SEC |
| Innoven Partenaires S.A. (IPSA), Innoven 2002 FCPI N°6, Innoven 2003 FCPI N°7, FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Europe 3, FCPI Innoven Capital, FCPI Innoven Capital 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI Poste Innovation 9, FCPI La Banque Postale Innovation 1, Jean-Michel Paulhac, Thomas Balland ×2 filings | June 16, 2017 | · | Initial filing | Passive investment | SEC |
| FCPR Ventech A, FCPR Ventech B, FCPR Ventech Coinvest, FCPR Ventech Capital II, Alain Caffi, Jean Bourcereau ×2 filings | June 16, 2017 | · | Initial filing | Passive investment | SEC |
| Stephen From | March 4, 2015 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 29 insiders · 9 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Brian M. Strem | President and CEO | July 1, 2026 F | 58,823 | 0 | 0 | $0 |
| Melissa Tosca | CFO | July 1, 2026 F | 26,064 | 0 | 0 | $0 |
| Sarah Romano | Chief Financial Officer | Feb. 10, 2022 F | 22,746 | 0 | 0 | $0 |
| Ryan Randall Brenneman | Chief Financial Officer | July 18, 2016 A | · | 0 | 0 | $0 |
| Stephen From | Executive Chairman | Jan. 5, 2022 F | 67,693 | 0 | 0 | $0 |
| Brenda Mann | VP of Research & Development | Nov. 2, 2021 F | 15,136 | 0 | 0 | $0 |
| MANZO MICHAEL P. | VP of Engineering | Aug. 3, 2021 F | 15,378 | 0 | 0 | $0 |
| Barbara Wirostko | Chief Medical Officer | Aug. 6, 2019 F | 403,893 | 0 | 0 | $0 |
| Michael Garanzini | Chief Commercial Officer | July 10, 2018 A | 196,250 | 0 | 0 | $0 |
| Erin Parsons | Director | June 10, 2026 A | 5,260 | 0 | 0 | $0 |
| Carmine N. Stengone | Director | June 10, 2026 A | 1,250 | 0 | 0 | $0 |
| Aron Shapiro | Director | June 10, 2026 A | 3,000 | 0 | 0 | $0 |
| David Hollander | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Lisa Walters-Hoffert | Director | June 10, 2026 A | 1,250 | 0 | 0 | $0 |
| Praveen Tyle | Director | June 10, 2026 A | 5,014 | 0 | 0 | $0 |
| Morton Goldberg | Director | Feb. 1, 2021 A | 0 | 0 | 0 | $0 |
| Thomas Hancock | Director | Feb. 1, 2021 A | 13,487 | 0 | 0 | $0 |
| Peter Greenleaf | Director | Feb. 1, 2019 A | · | 0 | 0 | $0 |
| Thomas Balland | Director | June 21, 2017 A | 10,422 | 0 | 0 | $0 |
| Mounia Chaoui | Director | March 29, 2016 A | 10,422 | 0 | 0 | $0 |
| Ventech Capital II | 10% owner | March 13, 2017 S | 1,431,814 | 0 | 0 | $0 |
| NATIXIS PRIVATE EQUITY | 10% owner | Feb. 19, 2015 C | 674,205 | 0 | 0 | $0 |
| IPSA (INNOVEN PARTENAIRES S.A.) | 10% owner | Feb. 19, 2015 C | 1,460,479 | 0 | 0 | $0 |
| Keith J. Lane | · | Sept. 17, 2026 A | · | 0 | 0 | $0 |
| Eric Joseph Daniels | · | April 1, 2026 F | 31,741 | 0 | 0 | $0 |
| Kenneth L Gayron | · | Sept. 29, 2023 A | · | 0 | 0 | $0 |
| Paul G Chaney | · | March 3, 2023 A | 91,229 | 0 | 0 | $0 |
| Franz Obermayr | · | Feb. 1, 2021 A | · | 0 | 0 | $0 |
| Bernard Malfroy-Camine | · | Feb. 1, 2021 A | 61,525 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
KPRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$12.00
+368.7%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-03Mean target $12.00 +368.7%
Low$12.00
Mean$12.00
High$12.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 7, 2026